Corporate Finance & Consulting  
 
 
Home Page > Replicon Group
 



Oversol Oy / Lumi Group Oy Raises First Part of 2-4 M€ Financing
04-05-2010,

After 3 year development work Oversol Oy launched revolutionary LED based street light, LUMI R, in February 2010. Simultaneously it formed a spin-off company Lumi Group Oy for marketing and further development of LUMI R series (pat.pending). By the end of April first part of the 2-4 million euro financing round was finalized. Replicon was the exclusive financial adviser of the company in the financing.

LUMI R street light consumes over 40 % less energy than equivalent traditional product. At the same time the quality of the light is improved notably. Combined with the light control system up to 85 % energy savings can be achieved.

First LUMI R light was optimized into 10 meter poles. With the new financing LUMI R series will be expanded into 6, 8 and 12 meter poles.

During next 5 – 10 years the market for replacements in street lighting is expected to grow very rapidly due to new energy savings and environmental regulations in EU and else where in OECD countries. LED technology is both energy saving and environmentally friendly.

For further information on LUMI R sales, please contact:
+358 44 572 0063

Replicon facilitated the financing process inter alia by

1) Consulting in preparation of the marketing material
2) Informing some 100-200 active investors and business angels
3) Planning and finalizing the term sheet for the Financing Arrangement
4) Organizing the DD process and required materials
5) Consulting and finalizing new Shareholders’ Agreement for Oversol Oy and Lumi Group Oy.

Further details of this + 1 million euro financing round will be kept confidential. Lumi Group and Replicon Group have agreed to continue their collaboration in financial advisory and business development.

For further information on Replicon services, please contact:
+358 9 677 464

Petteri Hirvonen,
CEO, Replicon Group +358 50 552 96 33 (direct)

petteri.hirvonen@replicongroup.com

About Replicon

Replicon Group is an independent corporate finance, consulting and asset management advisory house for growth companies and growth investors. Replicon provides strategic and financial solutions that facilitate business activities, efficiency, and increase profitability of corporations and other organizations. Our core competence is in the corporate solutions that facilitate and govern growth of businesses based on innovation. An important part of our activities is continuous learning. We want to find and develop most suitable solutions to our customer needs. Replicon Group’s special focus areas are Cleantech, Life-Science and ICT/Mobile sectors. In these sectors Replicon provides also asset management advisory. The main shareholders in Replicon Group are its key management, holding majority of the company’s shares. Replicon’s homepage is www.replicon.fi.


Recent articles:

> 19-08-2010 - Valuation Services and Total Life Cycle Cost Analyses

> 04-05-2010 - Oversol Oy / Lumi Group Oy Raises First Part of 2-4 M€ Financing

> 22-03-2010 - Replicon Continues as Certified Adviser in NASDAQ OMX First North

> 22-03-2010 - Replicon Group jatkaa NASDAQ OMX:ssä neuvonantajana

> 22-01-2010 - Replicon Initiates Multimillion Financing Project for Promising LED Application

> 06-10-2009 - Replicon Newsletter Q3/2009

> 09-09-2009 - New Certification for Replicon Group

> 24-08-2009 - Replicon toimittaa asiantuntija-palvelupaketin Qentinel Oy:lle

> 17-08-2009 - ASIAVIIHDE: videoidut talouskirja-arvostelut

> 16-06-2009 - Replicon Group Company Awarded 2 Year R&D Project

> 21-05-2009 - Replicon Newsletter Q2/2009

> 21-05-2009 - Repliconin Uutiskirje Q2/2009

> 03-02-2009 - Replicon Newsletter Q1/2009

> 19-01-2009 - Jouko Ahvenainen Presenting in Mobile World Congress in Barcelona

> 19-12-2008 - Replicon Creates an Option Arrangement for Its Client

> 29-10-2008 - Results from Client Survey

> 18-09-2008 - Tuottavuus ja rahoitus 2008 -seminaari

> 17-06-2008 - Ani Biotech buys the Business Operations of Orgenium Laboratories

> 20-05-2008 - Tietoisku FIRST NORTH -markkinapaikasta

> 31-03-2008 - Replicon Collaboration Partner Forms Global Multi-Centre Network

> 30-01-2008 - Replicon helps EVE to Receive Private Equity Financing

> 29-01-2008 - Replicon Pharma Portfolio Outperforms Benchmark Index Fifth Year in a Row

> 29-11-2007 - Replicon Group OMX First Northin Certified Adviseriksi

> 29-11-2007 - Replicon Group becomes Certified Adviser in OMX First North

> 28-11-2007 - Matti Copeland Repliconin neuvonantajaksi

> 15-10-2007 - Replicon Private Equity -tapahtuma

> 24-09-2007 - Talentor Receives Private Equity Financing Package in Record Time

> 07-08-2007 - Meet Replicon in Autumn 2007

> 11-05-2007 - Replicon and Imanext Form Strategic Collaboration

> 17-04-2007 - Pääjohtaja Liikanen puhumassa Repliconin Tuottavuus -seminaarissa

> 17-04-2007 - BoF Governor Speaking at Replicon Productivity Seminar

> 09-03-2007 - Top Seminar: ICT Companies as Productivity Boosters

> 08-03-2007 - Xtract raises € 2 million in venture capital funding from Eqvitec

> 21-02-2007 - ICT-yritykset tuottavuuden nostajina - Repliconin Tuottavuus ja rahoitus -seminaari 17.4.2007

> 29-01-2007 - Replicon MDF Portfolio Outperforms Benchmark Index Fourth Year in a Row

> 29-01-2007 - Repliconin Pharma portfolio (MDF) ylittänyt jälleen vertailuindeksin tuoton

> 08-01-2007 - Replicon toimittaa asiantuntijapalvelupaketin Qentinel Oy:lle

> 15-12-2006 - Replicon Provides Expert Services for Xtract, Ltd.

> 01-11-2006 - Replicon Provides Compensation Arrangement Planning for Growth Companies

> 01-11-2006 - Replicon toteuttaa osakesidonnaisia kannustinjärjestelmiä kasvuyrityksille

> 26-10-2006 - Petteri Hirvonen Presenting in Global UMTS TDD Alliance Summit in London

> 28-09-2006 - Jouko Ahvenainen Presenting in Mobile Marketing Service Summit in Lisbon

> 29-05-2006 - First Half Management Consulting Projects of Replicon

> 01-04-2006 - Replicon Launches Investigational Asset Management Portfolio in ICT sector

> 02-03-2006 - Enfucell Receives First VC Round of Financing

> 20-02-2006 - Replicon Helps Arranging Significant Financing Package for a Client

> 29-01-2006 - Replicon Portfolio Outperforms Benchmark Third Year in a Row

> 02-01-2006 - Replicon Hires Satu Vapaakallio as Analyst

> 24-11-2005 - Replicon Initiate 7.5Meur Private Placement Process for SkyWeb Oy

> 14-10-2005 - CTT Cancer Targeting Technologies Ltd enters into R&D agreement with GE Healthcare

> 05-09-2005 - Orgenium receives financing from Abroad and Expands Production to Low Cost Production Site in Ankara, Turkey

> 20-07-2005 - Replicon helps arranging financing for #CMAX.gg

> 31-03-2005 - Replicon in BioFinland 05 Investor Forum

> 29-01-2005 - Replicon Biotech Value Portfolio Outperforms NASDAQ Biotech Index Second Year in a Row

> 26-01-2005 - Replicon Extends Its Life Science Expert Team

> 18-01-2005 - All Replicon Senior Partners Gain Accreditation by the Ministry of Trade and Industry

> 10-01-2005 - Jouko Ahvenainen (MBA, M.Sc.) joins Replicon as a Senior Partner

> 17-12-2004 - Replicon to Develop a Model for Enhancing Commercialization of Bone Research in Finland

> 29-10-2004 - Replicon moves to WTC Helsinki

> 15-10-2004 - MBA Petri Laulajainen joins Replicon as a Senior Partner

> 02-07-2004 - Orgenium closes financing round with private investors and Finnish Industry Investment Ltd.

> 27-05-2004 - Replicon's new strategic partners announced

> 07-04-2004 - Viope closes financing round for expansion

> 29-01-2004 - Replicon Biotech Model Portfolio Annual Return 78 per cent

> 15-12-2003 - Replicon enters into a two-year business development partnership

> 19-08-2003 - Dr. Hannu Silvennoinen joins as a Senior Partner

> 09-04-2003 - Replicon forms corporate finance unit

> 28-01-2003 - Replicon Launches Model Portfolio in Biotech

 
© 2003, Replicon